These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9407432)

  • 1. Mechanisms of progression in autosomal dominant polycystic kidney disease.
    Grantham JJ
    Kidney Int Suppl; 1997 Dec; 63():S93-7. PubMed ID: 9407432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease.
    Grantham JJ; Schreiner GF; Rome L; Grenz L; Joly A
    Proc Assoc Am Physicians; 1997 Jul; 109(4):397-408. PubMed ID: 9220537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic kidney disease: huge kidneys, huge problems, huge progress.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 1997; 108():165-70; discussion 170-2. PubMed ID: 9108675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
    Sessa A; Ghiggeri GM; Turco AE
    J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.
    Grantham JJ; Chapman AB; Torres VE
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):148-57. PubMed ID: 17699202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant polycystic kidney disease: time for a change?
    Chapman AB
    J Am Soc Nephrol; 2007 May; 18(5):1399-407. PubMed ID: 17429048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin and autosomal dominant polycystic kidney disease.
    Wüthrich RP; Serra AL
    Transplant Proc; 2009; 41(6 Suppl):S18-20. PubMed ID: 19651290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease.
    Wilson PD; Du J; Norman JT
    Eur J Cell Biol; 1993 Jun; 61(1):131-8. PubMed ID: 8223698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and loss of renal tissue in polycystic kidney diseases.
    Woo D
    N Engl J Med; 1995 Jul; 333(1):18-25. PubMed ID: 7776989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease.
    Chang MY; Parker E; El Nahas M; Haylor JL; Ong AC
    J Am Soc Nephrol; 2007 Feb; 18(2):560-9. PubMed ID: 17202412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to inhibit cyst formation in ADPKD.
    Calvet JP
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1205-11. PubMed ID: 18434615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease.
    Ye M; Grantham JJ
    N Engl J Med; 1993 Jul; 329(5):310-3. PubMed ID: 8321258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
    Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP
    J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse.
    Yoo KH; Kim YN; Lee MJ; Seong JK; Park JH
    Proteomics; 2009 Aug; 9(15):3824-32. PubMed ID: 19637234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal failure and cystic kidney diseases].
    Correas JM; Joly D; Chauveau D; Richard S; Hélénon O
    J Radiol; 2011 Apr; 92(4):308-22. PubMed ID: 21549887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
    Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
    J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.